Phase II Randomized Study of Salvage Radiation Therapy (SRT) plus Enzalutamide or Blinded Placebo for High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy: The SALV-ENZA Trial

Autor: P.T. Tran, K. Lowe, H. Wang, H.L. Tsai, D. Song, A.Y. Hung, J.W.D. Hearn, S.R. Miller, T.L. Lotan, T.L. DeWeese, M.D. Orton, C. Deville Jr, S. Liauw, E. Heath, S.C. Greco, N.B. Desai, D.E. Spratt, F.Y. Feng, T. Beer, E. Antonarakis
Rok vydání: 2022
Předmět:
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 114:S37
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2022.07.397
Databáze: OpenAIRE